Baricitinib experience on STING-associated vasculopathy with onset in infancy: A representative case from Turkey

Activated STING in a Vascular and Pulmonary Syndrome

Adriana A. de Jesus, Bernadette Marrero, Dan Yang et al. · New England Journal of Medicine · 2014 · 1.4K citations · Full text

Medicine, Immunology, Pathology +14

Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations

Nadia Jeremiah, Bénédicte Neven, Matteo Gentili et al. · Journal of Clinical Investigation · 2014 · 546 citations · Full text

Life Sciences, Genetics, Immunology +17

Familial chilblain lupus due to a gain-of-function mutation in STING

N. König, Christoph Fiehn, Christine Wolf et al. · Annals of the Rheumatic Diseases · 2016 · 304 citations · Full text

Life Sciences, Genetics, Immunology +14

Severe Pulmonary Fibrosis as the First Manifestation of Interferonopathy (TMEM173 Mutation)

Cécile Picard, Guillaume Thouvenin, Caroline Kannengiesser et al. · CHEST Journal · 2016 · 135 citations · Full text

Medicine, Immunology, Pathology +16

Pharmacokinetics, Pharmacodynamics, and Proposed Dosing of the Oral JAK1 and JAK2 Inhibitor Baricitinib in Pediatric and Young Adult CANDLE and SAVI Patients

Hanna Kim, Kristina M. Brooks, Cheng Cai Tang et al. · Clinical Pharmacology & Therapeutics · 2017 · 131 citations

Pharmacy, Pharmacokinetics, Pharmacology +17